Business Insider is off tomorrow in commemoration of Juneteenth, so your next edition of Dispensed will arrive on Monday.
First up today, Kimberly Leonard reports that Democrats in the House of Representatives are planning to vote on a bill that’s designed to strengthen the Affordable Care Act.
The bill almost certainly won’t become law. It’s unlikely that the Republican-controlled Senate will take it up. Instead, Kimberly reports, the goal is to highlight the differences between Democrats in favor of the bill and the Republicans who oppose it going into the 2020 elections.
Included in the bill so far: more subsidies for private insurance, more money to get the word out about the ACA, limiting short-term insurance plans, and considering extending the amount of time mothers are eligible for Medicaid after giving birth.
Not included: Anything about a public option, or lowering the age for Medicare eligibility from 65 to 60.
Democrats are preparing a bill to bolster Obamacare and repeat their winning 2018 strategy as Biden takes on Trump. Insiders revealed four key elements of the bill.
The CEO of one of the world’s largest generic drugmakers tells us why he’s making a $50 million bet on CBD
- Perrigo is paying $50 million for a 20% stake in Kazmira, a Colorado-based CBD manufacturer.
- To evaluate CBD deals, Perrigo CEO Murray Kessler told Business Insider that the generic drugmaker set up a small team to evaluate the claims CBD companies made about their products and technology.
- Kessler said CBD could be a $20 billion opportunity, and that those opportunities don’t come along often.